Relative bioavailability, immunogenicity, and safety of two adalimumab-adbm formulations in healthy volunteers: a double-blind, randomized, single-dose, parallel-arm Phase I trial (VOLTAIRE-HCLF)
Moschetti, Viktoria, Buschke, Susanne, Bertulis, Julia, Hohl, Kathrin, McCabe, Dorothy
Published in Expert opinion on biological therapy (02.07.2024)
Published in Expert opinion on biological therapy (02.07.2024)
Get more information
Journal Article
Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
Lingvay, Ildiko, Beetz, Nadine, Sennewald, Regina, Schuler-Metz, Annette, Bertulis, Julia, Loley, Christina, Lang, Benjamin, Lippert, Caroline, Lee, Jisoo, Manning, Linda Shapiro, Terada, Derek
Published in Postgraduate medicine (18.05.2020)
Published in Postgraduate medicine (18.05.2020)
Get full text
Journal Article